HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mazanet, M. M. Articles by Hughes, C. C. W. Search for Related Content PubMed PubMed Citation Articles by Mazanet, M. M. Articles by Hughes, C. C. W.

Expression of IFN-Inducible T Cell Chemoattractant by Human Endothelial Cells Is Cyclosporin A-Resistant and Promotes T Cell Adhesion: Implications for Cyclosporin A-Resistant Immune Inflammation¹

Melissa M. Mazanet^*, Kuldeep Neote and Christopher C. W. Hughes^2,*

^* Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697; and Department of Molecular Sciences, Pfizer Inc., Groton, CT 06340

IFN-inducible T cell chemoattractant (I-TAC) is a recently discovered member of the CXC chemokine family. It is a potent T cell chemoattractant expressed by IFN--treated astrocytes, monocytes, keratinocytes, bronchial epithelial cells, and neutrophils. In this study, we show that I-TAC is also expressed by IFN--treated endothelial cells (EC), both at the mRNA and protein levels. Induction of the I-TAC message is rapid and sustained over 24 h. TNF- does not induce I-TAC mRNA alone, but does act synergistically with IFN-. Blocking Abs to I-TAC, or to its receptor, CXCR3, reduce T cell adhesion to EC monolayers demonstrating that the expressed protein is functional. Finally, the expression of I-TAC by EC is resistant to the immunosuppressive drug cyclosporin A, suggesting that I-TAC may contribute to the chronic immune inflammation characteristic of graft arteriosclerosis.

This article has been cited by other articles:

				S. Wang, B. Lu, P. Wood, and R. D. Lund Grafting of ARPE-19 and Schwann Cells to the Subretinal Space in RCS Rats Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2552 - 2560. [Abstract] [Full Text] [PDF]

				V. Petkovic, C. Moghini, S. Paoletti, M. Uguccioni, and B. Gerber I-TAC/CXCL11 is a natural antagonist for CCR5 J. Leukoc. Biol., September 1, 2004; 76(3): 701 - 708. [Abstract] [Full Text] [PDF]

				X. H. Wang, Y. Zhu, Q. L. Feng, F. Z. Cui, and J. B. Ma Responses of Osteo- and Fibroblast Cells to Phosphorylated Chitin Journal of Bioactive and Compatible Polymers, March 1, 2003; 18(2): 135 - 146. [Abstract] [PDF]

				K. Mohan, Z. Ding, J. Hanly, and T. B. Issekutz IFN-{gamma}-Inducible T Cell {alpha} Chemoattractant Is a Potent Stimulator of Normal Human Blood T Lymphocyte Transendothelial Migration: Differential Regulation by IFN-{gamma} and TNF-{alpha} J. Immunol., June 15, 2002; 168(12): 6420 - 6428. [Abstract] [Full Text] [PDF]

				K. Singbartl, J. Thatte, M. L. Smith, K. Wethmar, K. Day, and K. Ley A CD2-Green Fluorescence Protein-Transgenic Mouse Reveals Very Late Antigen-4-Dependent CD8+ Lymphocyte Rolling in Inflamed Venules J. Immunol., June 15, 2001; 166(12): 7520 - 7526. [Abstract] [Full Text] [PDF]

				W. W. Hancock, B. Lu, W. Gao, V. Csizmadia, K. Faia, J. A. King, S. T. Smiley, M. Ling, N. P. Gerard, and C. Gerard Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection J. Exp. Med., November 20, 2000; 192(10): 1515 - 1520. [Abstract] [Full Text] [PDF]